-
Board Certification
American Board of SurgeryPatient Rating
4.9 /5( out of 149 reviews )The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.
The scale on which responses are measured is 1 to 5 with 5 being the best score.
Patient Comments
Patient comments are gathered from our patient experience survey and displayed in their entirety.
Patients are de-identified for confidentiality and patient privacy.June 29, 2024HUNTSMAN CANCER CENTERCaring and knowledgeable
June 28, 2024HUNTSMAN CANCER CENTERMs Rosenthal was calm, positive and confident about my upcoming surgery and follow up treatment. She explained every step and answered all questions. This helped me to be positive about my future!
June 27, 2024HUNTSMAN CANCER CENTERDr. Rosenthal was so compassionate and very respectful when I spoke about my concerns and fears. I'm confident that I'm in the best of hands with my surgeon.
June 22, 2024HUNTSMAN CANCER CENTERShe is amazing! Straight forward with the results and treatment options.
June 19, 2024HUNTSMAN CANCER CENTERDr. Rosenthal is such a powerful presence. She cares so much about her patients. She gives me confidence that I can get well. I feel so secure around her, she¿s a very capable doctor, with a big heart. I¿m so pleased with the surgery she preformed on me. I know that she spent a lot of time making sure she got all the cancer, and she was so careful not to cause any harm. I would highly recommend her to anyone.
June 14, 2024HUNTSMAN CANCER CENTERI would prefer less online communication
June 08, 2024HUNTSMAN CANCER CENTERDr. Rosenthal is a very skilled and talented surgeon. She also educates and explains in detail all aspects of breast cancer and its treatment. She understands the stresses and emotional toll cancer takes and is very empathetic.
May 29, 2024HUNTSMAN CANCER CENTERDr. Rosenthal is confident and competent. She has a pleasant, unhurried manner and focuses completely on her patient. Her explanations are clear and succinct, she is very thorough in her examinations and in explaining test results. She allows plenty of time for questions, and encourages her patients to do their own research in order to be able to make informed decisions.
May 24, 2024HUNTSMAN CANCER CENTERWe appreciate Dr. Rosenthal so much. She was very compassionate and addressed our every concern. We feel she was very thorough with her explanations, and addressed every question, giving us clarity every step of the way.
-
Board Certification and Academic Information
Academic Departments Surgery -Primary Board Certification American Board of SurgeryEducation history
Research Fellow Oncology - Boston University Medical Center Research Fellow Boston University Administrative Chief Resident Residency Boston University Resident Boston University Intern Professional Medical Medicine - Albert Einstein College of Medicine M.D. Biochemistry - City College of New York B.S. Selected Publications
Journal Article
- Covington MF, Hoffman JM, Morton KA, Buckway B, Boucher KM, Rosenthal R, Porretta J, Brownson KE, Matsen CB, Vaklavas C, Ward JH, Wei M, Buys SS, Chittoria N, Yakish ED, Archibald ZG, Burrell LD, Butterfield RI, Yap JT (2023). Prospective Pilot Study of (18)F-Fluoroestradiol PET/CT in Patients With Invasive Lobular Carcinomas. AJR Am J Roentgenol, 221(2), 228-239. (Read full article)
- Erickson JR, Pahlkotter MK, Thielking PD, Porretta JM, Rosenthal R, Matsen CB, Brownson KE (2023). Leveraging telehealth supportive oncology services to combat COVID-19 isolation in breast cancer patients: A cancer center’s perspective. Patient Exp J, 10(2), 133-137.
- Erickson JR, Pahlkotter MK, Thielking PD, Porretta JM, Rosenthal R, Matsen CB, Brownson KE (2023). Leveraging telehealth supportive oncology services to combat COVID-19 isolation in breast cancer patients: A cancer center’s perspective. Patient Exp J, 10(2), 133-137. (Read full article)
- Guillen KP, Fujita M, Butterfield AJ, Scherer SD, Bailey MH, Chu Z, DeRose YS, Zhao L, Cortes-Sanchez E, Yang CH, Toner J, Wang G, Qiao Y, Huang X, Greenland JA, Vahrenkamp JM, Lum DH, Factor RE, Nelson EW, Matsen CB, Poretta JM, Rosenthal R, Beck AC, Buys SS, Vaklavas C, Ward JH, Jensen RL, Jones KB, Li Z, Oesterreich S, Dobrolecki LE, Pathi SS, Woo XY, Berrett KC, Wadsworth ME, Chuang JH, Lewis MT, Marth GT, Gertz J, Varley KE, Welm BE, Welm AL (2022). A human breast cancer-derived xenograft and organoid platform for drug discovery and precision oncology. Nat Cancer, 3(2), 232-250. (Read full article)
-
News & Podcasts
Huntsman Cancer Institute News